干眼病患者Nod样受体表达及其与临床指标的相关性
横断面研究纳入50眼(SS-DE 23眼、非SS-DE 14眼、健康对照13眼),检测结膜Nod-1、IκKα、NF-κB表达。SS-DE与非SS-DE组Nod-1 mRNA及蛋白均较对照上调,且Nod-1表达与OSDI、Schirmer、CFS显著相关,与TBUT无关。提示Nod样受体可能参与干眼炎症启动。
要点
- SS-DE组Nod-1 mRNA上调3.48倍、蛋白上调2.71倍,均高于非SS-DE组。
- Nod-1表达与OSDI(r=0.78)、Schirmer(r=-0.66)、CFS(r=0.68)显著相关。
- Nod-1与TBUT无显著相关(r=0.08,P=0.66)。
核心结论
- 干眼患者结膜Nod-1表达升高,SS-DE尤为明显,且与疾病严重程度相关。
- Nod样受体表达可能参与干眼炎症反应的启动。
研究设计与样本
- 横断面研究,共50例50眼:SS-DE 23眼、非SS-DE 14眼、健康对照13眼。
- 采用结膜印迹细胞学和活检取材,以RT-qPCR和Western blot检测Nod-1、IκKα、NF-κB表达。
主要发现
- SS-DE组OSDI和CFS评分显著高于非SS-DE组,TBUT和Schirmer显著低于非SS-DE组(均P<.05)。
- SS-DE与非SS-DE组Nod-1 mRNA分别相对上调3.48倍和1.72倍(P<.01),IκKα上调1.83倍和1.24倍(P<.01),NF-κB上调1.84倍和1.32倍(P<.01)。
- Western blot示Nod-1蛋白在SS-DE与非SS-DE组分别相对上调2.71倍和1.64倍(P<.05),IκKα与NF-κB呈类似变化。
- 干眼患者中Nod-1与OSDI(R2=0.61,r=0.78,P<.01)、Schirmer(R2=0.44,r=-0.66,P<.01)、CFS(R2=0.46,r=0.68,P<.01)显著相关,与TBUT无显著相关(R2<0.01,r=0.08,P=.66)。
临床怎么用
- Nod-1表达水平与OSDI、Schirmer、CFS相关,可作为评估干眼严重程度的潜在炎症标志物。
- SS-DE患者Nod-1上调更明显,提示其炎症通路激活程度更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the expression pattern of nucleotide-binding oligomerization domain (Nod)-like receptors that detects "danger" intracellular signaling and its correlation with clinical dry eye (DE) markers. DESIGN: Cross-sectional study. METHODS: A total of 50 participants with 50 eyes were included: 23 eyes with Sjögren syndrome (SS)-DE, 14 eyes with non-SS-DE, and 13 healthy controls with non-DE. Ocular Surface Disease Index (OSDI) was self-answered and clinical tests including the tear film breakup time (TBUT), Schirmer test, and corneal fluorescein staining (CFS) were performed. Specimens for expression pattern analysis were obtained by conjunctival impression cytology and biopsy. Nod-1, inhibitor kappa B kinase-alpha (IκKα), and nuclear factor kappa B (NF-κB) expression was determined by reverse transcription quantitative real-time polymerase chain reaction and Western blot. Correlations between Nod-1 and ocular surface parameters were determined. RESULTS: Patients with SS-DE had significantly higher OSDI and CFS scores and lower TBUT and Schirmer test scores than those with non-SS-DE patients (all P < .05). Compared with the control group, both the SS-DE and non-SS-DE groups showed significant upregulation in mRNA expression levels of Nod-1 (relative 3.48-fold and 1.72-fold upregulation, respectively, P < .01), IκKα (relative 1.83-fold and 1.24-fold upregulation, respectively, P < .01), and NF-κB (relative 1.84-fold and 1.32-fold upregulation, respectively, P < .01). Western blot analysis showed that Nod-1 protein expression increased in both the SS-DE and non-SS-DE groups (relative 2.71-fold and 1.64-fold upregulation, respectively, P < .05) compared with that in the control group. Similar findings were observed for IκKα and NF-κB. In DE participants, the expression of Nod-1 significantly correlated with the OSDI (R2 = 0.61, r = 0.78, P < .01), Schirmer test score (R2 = 0.44, r = -0.66, P < .01), and CFS (R2 = 0.46, r = 0.68, P < .01) but did not significantly correlate with TBUT (R2 < 0.01, r = 0.08, P = .66). CONCLUSIONS: Nod-1 expression was increased in the conjunctiva of DE, especially SS-DE, and was associated with disease severity. Expression of Nod-like receptors might play an important role in initiating the inflammatory response in DE.
引用
- Kim YH, Li Z, Cui L, et al. Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease. Am J Ophthalmol. 2019. PMID: 30653959. doi:10.1016/j.ajo.2019.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。